Yuhan

Yuhan Corporation, founded in 1926, is a leading South Korean healthcare company, distinguished by its significant market capitalization and sales revenue. Operating within the pharmaceutical and healthcare sectors, Yuhan's core business includes primary and specialty care, dietary supplements, and household/animal care products. The company also provides contract manufacturing services for active pharmaceutical ingredients (APIs). Its global reach is enhanced through strategic joint ventures with international partners like Janssen (Belgium), The Clorox Company (USA), and Kimberly-Clark Corporation (USA).

Yuhan employs between 1,000 and 5,000 individuals and operates from a single primary location. The company achieved a revenue of $1.4 billion, reflecting its substantial economic impact. To understand the driving force behind its operations and market strategies, one can explore Meet Yuhan's team. This focus on its personnel underpins Yuhan's capacity for innovation and expansion across its diverse healthcare offerings.

As a publicly-traded company on the Korea Stock Exchange (KRX: 000100), Yuhan leverages its extensive history and strategic alliances. Its product portfolio spans pharmaceuticals, nutritional supplements, and consumer health goods. Yuhan's dedication to R&D and its established market presence are key factors in its sustained growth and competitive standing within the global healthcare industry.